Skip to main content
Erschienen in: Current Treatment Options in Gastroenterology 4/2014

01.12.2014 | Motility (T Lembo, Section Editor)

Management of Pelvic Floor Disorders: Biofeedback and More

verfasst von: David Prichard, MB, PhD, Adil E. Bharucha, MBBS, MD

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Opinion statement

Defecatory disorders (DD) and fecal incontinence (FI) are common conditions. DD are primarily attributable to impaired rectoanal function during defecation or structural defects. FI is caused by one or more disturbances of anorectal continence mechanisms. Altered stool consistency may be the primary cause or may unmask anorectal deficits in both conditions. Diagnosis and management requires a systematic approach beginning with a thorough clinical assessment. Symptoms do not reliably differentiate a DD from other causes of constipation such as slow or normal transit constipation. Therefore, all constipated patients who do not adequately respond to medical therapy should be considered for anorectal testing to identify a DD. Preferably, two tests indicating impaired defecation are required to diagnose a DD. Patients with DD, or those for whom testing is not available and the clinical suspicion is high, should be referred for biofeedback-based pelvic floor physical therapy. Patients with FI should be managed with lifestyle modifications, pharmacotherapy for bowel disturbances, and management of local anorectal problems (e.g., hemorrhoids). When these measures are not beneficial, anorectal testing and pelvic floor retraining with biofeedback therapy should be considered. Sacral nerve stimulation or perianal bulking could be considered in patients who have persistent symptoms despite optimal management of bowel disturbances and pelvic floor retraining.
Literatur
1.
Zurück zum Zitat Wald A et al. Functional anorectal disorders. In: Drossman DA, Corazziari E, Delvaux M, et al., editors. Rome III: the functional gastrointestinal disorders. McLean: Degnon Associates, Inc; 2006. p. 639–86. Wald A et al. Functional anorectal disorders. In: Drossman DA, Corazziari E, Delvaux M, et al., editors. Rome III: the functional gastrointestinal disorders. McLean: Degnon Associates, Inc; 2006. p. 639–86.
3.
Zurück zum Zitat American Gastroenterological Association. American gastroenterological association medical position statement on constipation. Gastroenterology. 2013;144(1):211–7.CrossRef American Gastroenterological Association. American gastroenterological association medical position statement on constipation. Gastroenterology. 2013;144(1):211–7.CrossRef
4.
Zurück zum Zitat Chiarioni G et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657–64.PubMedCrossRef Chiarioni G et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657–64.PubMedCrossRef
5.
Zurück zum Zitat Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129(1):86–97.PubMedCrossRef Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129(1):86–97.PubMedCrossRef
6.
Zurück zum Zitat Noelting J, Zinsmeister AR, Bharucha AE. Comparison of daily and weekly instruments of patient-reported outcomes for therapeutic trials in fecal incontinence (FI). Gastroenterology 2014;146(5):S-718;Mo2016. Noelting J, Zinsmeister AR, Bharucha AE. Comparison of daily and weekly instruments of patient-reported outcomes for therapeutic trials in fecal incontinence (FI). Gastroenterology 2014;146(5):S-718;Mo2016.
7.
Zurück zum Zitat Tremaine WJ et al. 561 Inflammatory bowel disease and nonrRelaxing pelvic floor dysfunction. Gastroenterology. 2013;144(5):S-104. Tremaine WJ et al. 561 Inflammatory bowel disease and nonrRelaxing pelvic floor dysfunction. Gastroenterology. 2013;144(5):S-104.
8.•
Zurück zum Zitat Perera L et al. Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission. Dig Dis Sci. 2013;58(12):3600–5. In this observational study, 29 of 30 patients with IBC who had persistent defecatory symptoms in the absence of left colonic inflammation had evidence of dyssynergia on anorectal testing. This research demonstrates the very high prevalence of DD in this cohort and highlights that a diagnosis of DD should be considered in all patients who continue to have symptoms despite apparently successful therapy for their IBD.PubMedCrossRef Perera L et al. Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission. Dig Dis Sci. 2013;58(12):3600–5. In this observational study, 29 of 30 patients with IBC who had persistent defecatory symptoms in the absence of left colonic inflammation had evidence of dyssynergia on anorectal testing. This research demonstrates the very high prevalence of DD in this cohort and highlights that a diagnosis of DD should be considered in all patients who continue to have symptoms despite apparently successful therapy for their IBD.PubMedCrossRef
9.
Zurück zum Zitat Vijayvargiya P et al. Novel association of rectal evacuation disorder and rumination syndrome: diagnosis, co-morbidities and treatment. United Eur Gastroenterol J. 2014;2(1):38–46.CrossRef Vijayvargiya P et al. Novel association of rectal evacuation disorder and rumination syndrome: diagnosis, co-morbidities and treatment. United Eur Gastroenterol J. 2014;2(1):38–46.CrossRef
10.
Zurück zum Zitat Videlock EJ, Lembo A, Cremonini F. Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis. Neurogastroenterol Motil. 2013;25(6):509–20.PubMedCrossRef Videlock EJ, Lembo A, Cremonini F. Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis. Neurogastroenterol Motil. 2013;25(6):509–20.PubMedCrossRef
11.
Zurück zum Zitat Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology. 2004;126(1):57–62. Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology. 2004;126(1):57–62.
12.
Zurück zum Zitat Ratuapli S et al. Comparison of rectal balloon expulsion test in seated and left lateral positions. Neurogastroenterol Motil. 2013;25(12):e813–20.PubMedCrossRef Ratuapli S et al. Comparison of rectal balloon expulsion test in seated and left lateral positions. Neurogastroenterol Motil. 2013;25(12):e813–20.PubMedCrossRef
13.••
Zurück zum Zitat Chiarioni G, et al. Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol 2014. Access to anorectal testing (ARM, electromyography, and defecography) is limited in community practice. This research demonstrates the high level of agreement between BET and ARM (78 %) and/or electromyography (83 %). The BET is a simple, cheap, and valid test that can be used to screen for DD among constipated patients responding incompletely to conservative therapy in the community. Chiarioni G, et al. Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol 2014. Access to anorectal testing (ARM, electromyography, and defecography) is limited in community practice. This research demonstrates the high level of agreement between BET and ARM (78 %) and/or electromyography (83 %). The BET is a simple, cheap, and valid test that can be used to screen for DD among constipated patients responding incompletely to conservative therapy in the community.
14.
Zurück zum Zitat Noelting J et al. Normal values for high-resolution anorectal manometry in healthy women: effects of age and significance of rectoanal gradient. Am J Gastroenterol. 2012;107(10):1530–6.PubMedCrossRefPubMedCentral Noelting J et al. Normal values for high-resolution anorectal manometry in healthy women: effects of age and significance of rectoanal gradient. Am J Gastroenterol. 2012;107(10):1530–6.PubMedCrossRefPubMedCentral
15.••
Zurück zum Zitat Ratuapli S et al. Phenotypic identification and classification of functional defecatory disorders using high resolution anorectal manometry. Gastroenterology. 2013;144:314–22. Principal component analysis of high-resolution manometry parameters in healthy controls (n = 62), constipated patients with a normal BET (n = 224), and constipated patients with an abnormal BET (n = 71) identified three manometric patterns associated with an abnormal BET (i.e., DD): (1) high anal tone at rest and during simulated evacuation, (2) inadequate rectal propulsive forces during simulated evacuation; and (3) a hybrid of the two. Clinical symptoms correlated only weakly with an abnormal BET or any of the manometric patterns suggestive of DD. This paper highlights that anorectal testing is crucial in identifying patients with DD.PubMedCrossRefPubMedCentral Ratuapli S et al. Phenotypic identification and classification of functional defecatory disorders using high resolution anorectal manometry. Gastroenterology. 2013;144:314–22. Principal component analysis of high-resolution manometry parameters in healthy controls (n = 62), constipated patients with a normal BET (n = 224), and constipated patients with an abnormal BET (n = 71) identified three manometric patterns associated with an abnormal BET (i.e., DD): (1) high anal tone at rest and during simulated evacuation, (2) inadequate rectal propulsive forces during simulated evacuation; and (3) a hybrid of the two. Clinical symptoms correlated only weakly with an abnormal BET or any of the manometric patterns suggestive of DD. This paper highlights that anorectal testing is crucial in identifying patients with DD.PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat Rao SS et al. Manometric tests of anorectal function in healthy adults. Am J Gastroenterol. 1999;94(3):773–83.PubMedCrossRef Rao SS et al. Manometric tests of anorectal function in healthy adults. Am J Gastroenterol. 1999;94(3):773–83.PubMedCrossRef
17.•
Zurück zum Zitat Wald A et al. ACG clinical guidelines: management of benign anorectal disorders. Am J Gastroenterol. 2014;109(8):1141–57. This review paper is the most recent and comprehensive review of the literature relating to the definitions, diagnostic criteria, differential diagnoses, and treatments of benign anorectal disorders, including defecation disorders, fecal incontinence, proctalgia syndromes, anal fissure, and hemorrhoids.PubMedCrossRef Wald A et al. ACG clinical guidelines: management of benign anorectal disorders. Am J Gastroenterol. 2014;109(8):1141–57. This review paper is the most recent and comprehensive review of the literature relating to the definitions, diagnostic criteria, differential diagnoses, and treatments of benign anorectal disorders, including defecation disorders, fecal incontinence, proctalgia syndromes, anal fissure, and hemorrhoids.PubMedCrossRef
18.
Zurück zum Zitat Bharucha AE et al. Phenotypic variation in functional disorders of defecation. Gastroenterology. 2005;128:1199–210.PubMedCrossRef Bharucha AE et al. Phenotypic variation in functional disorders of defecation. Gastroenterology. 2005;128:1199–210.PubMedCrossRef
20.
Zurück zum Zitat Woodward S, Norton C, Chiarelli P. Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database Syst Rev. 2014;3, CD008486.PubMed Woodward S, Norton C, Chiarelli P. Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database Syst Rev. 2014;3, CD008486.PubMed
21.•
Zurück zum Zitat Jodorkovsky D et al. Biofeedback therapy for defecatory dysfunction: “real life” experience. J Clin Gastroenterol. 2013;47(3):252–5. Randomized trials demonstrate that biofeedback therapy is effective for DD and FI. In this retrospective review from a tertiary referral center, less than 50 % of patients with constipation or FI in whom biofeedback-based pelvic floor retraining was recommended underwent biofeedback therapy because of limitations related to a lack of insurance coverage, travel to facilities, and acute medical issues taking precedence. However, the response rate was similar to that reported in clinical trials.PubMedCrossRef Jodorkovsky D et al. Biofeedback therapy for defecatory dysfunction: “real life” experience. J Clin Gastroenterol. 2013;47(3):252–5. Randomized trials demonstrate that biofeedback therapy is effective for DD and FI. In this retrospective review from a tertiary referral center, less than 50 % of patients with constipation or FI in whom biofeedback-based pelvic floor retraining was recommended underwent biofeedback therapy because of limitations related to a lack of insurance coverage, travel to facilities, and acute medical issues taking precedence. However, the response rate was similar to that reported in clinical trials.PubMedCrossRef
22.
Zurück zum Zitat Maria G et al. Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis Colon Rectum. 2000;43(3):376–80.PubMedCrossRef Maria G et al. Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis Colon Rectum. 2000;43(3):376–80.PubMedCrossRef
23.
Zurück zum Zitat Ron Y et al. Botulinum toxin type-A in therapy of patients with anismus. Dis Colon Rectum. 2001;44(12):1821–6.PubMedCrossRef Ron Y et al. Botulinum toxin type-A in therapy of patients with anismus. Dis Colon Rectum. 2001;44(12):1821–6.PubMedCrossRef
24.
Zurück zum Zitat Maria G et al. Experience with type A botulinum toxin for treatment of outlet-type constipation. Am J Gastroenterol. 2006;101(11):2570–5.PubMedCrossRef Maria G et al. Experience with type A botulinum toxin for treatment of outlet-type constipation. Am J Gastroenterol. 2006;101(11):2570–5.PubMedCrossRef
25.
26.
Zurück zum Zitat Knowles CH et al. Prospective randomized double-blind study of temporary sacral nerve stimulation in patients with rectal evacuatory dysfunction and rectal hyposensitivity. Ann Surg. 2012;255(4):643–9.PubMedCrossRef Knowles CH et al. Prospective randomized double-blind study of temporary sacral nerve stimulation in patients with rectal evacuatory dysfunction and rectal hyposensitivity. Ann Surg. 2012;255(4):643–9.PubMedCrossRef
27.
Zurück zum Zitat Farouk R, Bhardwaj R, Phillips RKS. Stapled transanal resection of the rectum (STARR) for the obstructed defaecation syndrome. Ann R Coll Surg Engl. 2009;91(4):287–91.PubMedCrossRefPubMedCentral Farouk R, Bhardwaj R, Phillips RKS. Stapled transanal resection of the rectum (STARR) for the obstructed defaecation syndrome. Ann R Coll Surg Engl. 2009;91(4):287–91.PubMedCrossRefPubMedCentral
28.
Zurück zum Zitat Harmston C et al. Comment on: Stapled transanal resection of the rectum (STARR) for obstructed defaecation syndrome. Ann R Coll Surg Engl. 2010;92(1):85–6.PubMedCrossRefPubMedCentral Harmston C et al. Comment on: Stapled transanal resection of the rectum (STARR) for obstructed defaecation syndrome. Ann R Coll Surg Engl. 2010;92(1):85–6.PubMedCrossRefPubMedCentral
29.
Zurück zum Zitat Lehur PA et al. Outcomes of stapled transanal rectal resection vs. biofeedback for the treatment of outlet obstruction associated with rectal intussusception and rectocele: a multicenter, randomized, controlled trial. Dis Colon Rectum. 2008;51(11):1611–8.PubMedCrossRef Lehur PA et al. Outcomes of stapled transanal rectal resection vs. biofeedback for the treatment of outlet obstruction associated with rectal intussusception and rectocele: a multicenter, randomized, controlled trial. Dis Colon Rectum. 2008;51(11):1611–8.PubMedCrossRef
30.
Zurück zum Zitat Gagliardi G et al. Results, outcome predictors, and complications after stapled transanal rectal resection for obstructed defecation. Dis Colon Rectum. 2008;51(2):186–95. discussion 195.PubMedCrossRef Gagliardi G et al. Results, outcome predictors, and complications after stapled transanal rectal resection for obstructed defecation. Dis Colon Rectum. 2008;51(2):186–95. discussion 195.PubMedCrossRef
31.
Zurück zum Zitat Reboa G et al. The impact of stapled transanal rectal resection on anorectal function in patients with obstructed defecation syndrome. Dis Colon Rectum. 2009;52(9):1598–604.PubMedCrossRef Reboa G et al. The impact of stapled transanal rectal resection on anorectal function in patients with obstructed defecation syndrome. Dis Colon Rectum. 2009;52(9):1598–604.PubMedCrossRef
32.
Zurück zum Zitat Titu LV et al. Stapled transanal rectal resection for obstructed defecation: a cautionary tale. Dis Colon Rectum. 2009;52(10):1716–22.PubMedCrossRef Titu LV et al. Stapled transanal rectal resection for obstructed defecation: a cautionary tale. Dis Colon Rectum. 2009;52(10):1716–22.PubMedCrossRef
33.
Zurück zum Zitat Schwandner T et al. Does the STARR procedure change the pelvic floor: a preoperative and postoperative study with dynamic pelvic floor MRI. Dis Colon Rectum. 2011;54(4):412–7.PubMedCrossRef Schwandner T et al. Does the STARR procedure change the pelvic floor: a preoperative and postoperative study with dynamic pelvic floor MRI. Dis Colon Rectum. 2011;54(4):412–7.PubMedCrossRef
34.
Zurück zum Zitat Corman ML et al. Consensus conference on the stapled transanal rectal resection (STARR) for disordered defaecation. Color Dis. 2006;8(2):98–101.CrossRef Corman ML et al. Consensus conference on the stapled transanal rectal resection (STARR) for disordered defaecation. Color Dis. 2006;8(2):98–101.CrossRef
35.
Zurück zum Zitat Dodi G et al. Bleeding, incontinence, pain and constipation after STARR transanal double stapling rectotomy for obstructed defecation. Tech Coloproctol. 2003;7(3):148–53.PubMedCrossRef Dodi G et al. Bleeding, incontinence, pain and constipation after STARR transanal double stapling rectotomy for obstructed defecation. Tech Coloproctol. 2003;7(3):148–53.PubMedCrossRef
36.
Zurück zum Zitat Madbouly K, Abbas K, Hussein A. Disappointing long-term outcomes after stapled transanal rectal resection for obstructed defecation. World J Surg. 2010;34(9):2191–6.PubMedCrossRef Madbouly K, Abbas K, Hussein A. Disappointing long-term outcomes after stapled transanal rectal resection for obstructed defecation. World J Surg. 2010;34(9):2191–6.PubMedCrossRef
37.
Zurück zum Zitat Bharucha AE et al. Prevalence and burden of fecal incontinence: a population based study in women. Gastroenterology. 2005;129:42–9.PubMedCrossRef Bharucha AE et al. Prevalence and burden of fecal incontinence: a population based study in women. Gastroenterology. 2005;129:42–9.PubMedCrossRef
39.
Zurück zum Zitat Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol. 1996;91(1):33–6.PubMed Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol. 1996;91(1):33–6.PubMed
40.
Zurück zum Zitat Boreham MK et al. Anal incontinence in women presenting for gynecologic care: prevalence, risk factors, and impact upon quality of life. Am J Obstet Gynecol. 2005;192(5):1637–42.PubMedCrossRef Boreham MK et al. Anal incontinence in women presenting for gynecologic care: prevalence, risk factors, and impact upon quality of life. Am J Obstet Gynecol. 2005;192(5):1637–42.PubMedCrossRef
41.
Zurück zum Zitat Bliss DZ, Norton C, Vodusek DB. Raising awareness about fecal incontinence. Neurourol Urodyn. 2010;29(4):612–5.PubMedCrossRef Bliss DZ, Norton C, Vodusek DB. Raising awareness about fecal incontinence. Neurourol Urodyn. 2010;29(4):612–5.PubMedCrossRef
42.••
Zurück zum Zitat Bharucha AE et al. Obstetric trauma, pelvic floor injury and fecal incontinence: a population-based case-control study. Am J Gastroenterol. 2012;107(6):902–11. This research used a nested case–control study to evaluate the antecedent risk factors for FI. Urgency (odds ratio [OR] [per 10 %] 3.0; 95 % confidence interval [CI] 1.4–6.5, p = 0.005) and stool consistency (OR [per unit] 10; 95 % CI 1.9–58, p = 0.008) were associated with an increased risk of FI, while anal and pelvic floor injuries were not. These findings suggest that, in community practice, initial emphasis should be placed on modifying bowel disturbances and toileting habits rather than identifying anatomical deficits of the anus and pelvic floor.PubMedCrossRefPubMedCentral Bharucha AE et al. Obstetric trauma, pelvic floor injury and fecal incontinence: a population-based case-control study. Am J Gastroenterol. 2012;107(6):902–11. This research used a nested case–control study to evaluate the antecedent risk factors for FI. Urgency (odds ratio [OR] [per 10 %] 3.0; 95 % confidence interval [CI] 1.4–6.5, p = 0.005) and stool consistency (OR [per unit] 10; 95 % CI 1.9–58, p = 0.008) were associated with an increased risk of FI, while anal and pelvic floor injuries were not. These findings suggest that, in community practice, initial emphasis should be placed on modifying bowel disturbances and toileting habits rather than identifying anatomical deficits of the anus and pelvic floor.PubMedCrossRefPubMedCentral
43.
Zurück zum Zitat Bharucha AE et al. Risk factors for fecal incontinence: a population based study in women. Am J Gastroenterol. 2006;101:1305–12.PubMedCrossRef Bharucha AE et al. Risk factors for fecal incontinence: a population based study in women. Am J Gastroenterol. 2006;101:1305–12.PubMedCrossRef
44.
Zurück zum Zitat Heymen S et al. Mo2024 Patient preference for what should be included in the definition of fecal incontinence. Gastroenterology. 2014;146(5):S-720–1.CrossRef Heymen S et al. Mo2024 Patient preference for what should be included in the definition of fecal incontinence. Gastroenterology. 2014;146(5):S-720–1.CrossRef
45.
Zurück zum Zitat Heymen S et al. Mo2025 Patient preference for defining success in fecal incontinence treatment trials. Gastroenterology. 2014;146(5):S-721.CrossRef Heymen S et al. Mo2025 Patient preference for defining success in fecal incontinence treatment trials. Gastroenterology. 2014;146(5):S-721.CrossRef
46.
Zurück zum Zitat Bharucha AE, Rao SSC. An update on anorectal disorders for gastroenterologists. Gastroenterology. 2014;146(1):37–45.e2.PubMedCrossRef Bharucha AE, Rao SSC. An update on anorectal disorders for gastroenterologists. Gastroenterology. 2014;146(1):37–45.e2.PubMedCrossRef
47.
Zurück zum Zitat Bliss DZ et al. Supplementation with dietary fiber improves fecal incontinence. Nurs Res. 2001;50(4):203–13.PubMedCrossRef Bliss DZ et al. Supplementation with dietary fiber improves fecal incontinence. Nurs Res. 2001;50(4):203–13.PubMedCrossRef
48.
Zurück zum Zitat Markland AD et al. 883 Fiber or imodium prescription (Rx) management for bowel incontinence: the FIRM randomized clinical trial. Gastroenterology. 2014;146(5):S-154–5.CrossRef Markland AD et al. 883 Fiber or imodium prescription (Rx) management for bowel incontinence: the FIRM randomized clinical trial. Gastroenterology. 2014;146(5):S-154–5.CrossRef
49.
Zurück zum Zitat Whitehead WE, et al. Treatment of fecal incontinence: state of the science and directions for future research. Am J Gastroenterol. 2014; In press. Whitehead WE, et al. Treatment of fecal incontinence: state of the science and directions for future research. Am J Gastroenterol. 2014; In press.
50.
Zurück zum Zitat Remes-Troche JM et al. Cholestyramine: a useful adjunct for the treatment of patients with fecal incontinence. Int J Color Dis. 2008;23(2):189–94.CrossRef Remes-Troche JM et al. Cholestyramine: a useful adjunct for the treatment of patients with fecal incontinence. Int J Color Dis. 2008;23(2):189–94.CrossRef
51.
Zurück zum Zitat Bharucha AE et al. Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 2014;12(5):843–851.e2.PubMedCrossRef Bharucha AE et al. Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 2014;12(5):843–851.e2.PubMedCrossRef
52.
Zurück zum Zitat Bharucha AE, Seide BM, Zinsmeister AR. The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence. Aliment Pharmacol Ther. 2010;32(5):681–8.PubMedPubMedCentral Bharucha AE, Seide BM, Zinsmeister AR. The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence. Aliment Pharmacol Ther. 2010;32(5):681–8.PubMedPubMedCentral
53.
Zurück zum Zitat Carapeti EA, Kamm MA, Phillips RK. Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg. 2000;87(1):38–42.PubMedCrossRef Carapeti EA, Kamm MA, Phillips RK. Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg. 2000;87(1):38–42.PubMedCrossRef
54.
Zurück zum Zitat Cheetham MJ, Kamm MA, Phillips RK. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut. 2001;48(3):356–9.PubMedCrossRefPubMedCentral Cheetham MJ, Kamm MA, Phillips RK. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut. 2001;48(3):356–9.PubMedCrossRefPubMedCentral
55.
Zurück zum Zitat Heymen S et al. Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum. 2009;52(10):1730–7.PubMedCrossRef Heymen S et al. Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum. 2009;52(10):1730–7.PubMedCrossRef
56.
Zurück zum Zitat Bharucha AE. Outcome measures for fecal incontinence: anorectal structure and function. Gastroenterology. 2004;126:S90–8.PubMedCrossRef Bharucha AE. Outcome measures for fecal incontinence: anorectal structure and function. Gastroenterology. 2004;126:S90–8.PubMedCrossRef
57.
Zurück zum Zitat Norton C et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology. 2003;125:1320–9.PubMedCrossRef Norton C et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology. 2003;125:1320–9.PubMedCrossRef
58.
Zurück zum Zitat Solomon MJ et al. Randomized, controlled trial of biofeedback with anal manometry, transanal ultrasound, or pelvic floor retraining with digital guidance alone in the treatment of mild to moderate fecal incontinence. Dis Colon Rectum. 2003;46(6):703–10.PubMedCrossRef Solomon MJ et al. Randomized, controlled trial of biofeedback with anal manometry, transanal ultrasound, or pelvic floor retraining with digital guidance alone in the treatment of mild to moderate fecal incontinence. Dis Colon Rectum. 2003;46(6):703–10.PubMedCrossRef
59.
Zurück zum Zitat Heymen S et al. Randomized controlled trial shows biofeedback to be superior to alternative treatments for fecal incontinence. Dis Colon Rectum. 2009;52:1730–7.PubMedCrossRef Heymen S et al. Randomized controlled trial shows biofeedback to be superior to alternative treatments for fecal incontinence. Dis Colon Rectum. 2009;52:1730–7.PubMedCrossRef
60.
61.
Zurück zum Zitat Graf W et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet. 2011;377(9770):997–1003.PubMedCrossRef Graf W et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet. 2011;377(9770):997–1003.PubMedCrossRef
62.
Zurück zum Zitat Mellgren A et al. Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil. 2014;26(8):1087–94.PubMedCrossRef Mellgren A et al. Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil. 2014;26(8):1087–94.PubMedCrossRef
63.
Zurück zum Zitat Dehli T et al. Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol. 2013;48(3):302–10.PubMedCrossRef Dehli T et al. Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol. 2013;48(3):302–10.PubMedCrossRef
64.
Zurück zum Zitat Wexner SD et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg. 2010;251(3):441–9.PubMedCrossRef Wexner SD et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg. 2010;251(3):441–9.PubMedCrossRef
65.
Zurück zum Zitat Mellgren A et al. Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum. 2011;54(9):1065–75.PubMedCrossRef Mellgren A et al. Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum. 2011;54(9):1065–75.PubMedCrossRef
66.••
Zurück zum Zitat Hull T et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):234–45. This paper 5-year follow-up data from patients who had permanent SNS implantation for refractory FI. Among the 63 % of the original cohort available for analysis, FI episodes per week decreased from a mean of 9.1 at baseline to 1.7 at 5 years, with 89 % of patients having ≥50 % improvement and 36 % having complete continence. These data demonstrate that SNS is both effective and durable in treating FI refractory to conservative management.PubMedCrossRef Hull T et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):234–45. This paper 5-year follow-up data from patients who had permanent SNS implantation for refractory FI. Among the 63 % of the original cohort available for analysis, FI episodes per week decreased from a mean of 9.1 at baseline to 1.7 at 5 years, with 89 % of patients having ≥50 % improvement and 36 % having complete continence. These data demonstrate that SNS is both effective and durable in treating FI refractory to conservative management.PubMedCrossRef
67.
Zurück zum Zitat Patton V et al. The effect of sacral nerve stimulation on distal colonic motility in patients with faecal incontinence. Br J Surg. 2013;100(7):959–68.PubMedCrossRef Patton V et al. The effect of sacral nerve stimulation on distal colonic motility in patients with faecal incontinence. Br J Surg. 2013;100(7):959–68.PubMedCrossRef
68.
Zurück zum Zitat Thomas GP et al. A review of posterior tibial nerve stimulation for faecal incontinence. Color Dis. 2013;15(5):519–26.CrossRef Thomas GP et al. A review of posterior tibial nerve stimulation for faecal incontinence. Color Dis. 2013;15(5):519–26.CrossRef
69.
Zurück zum Zitat Leroi AM et al. Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (consort 1a). Am J Gastroenterol. 2012;107(12):1888–96.PubMedCrossRef Leroi AM et al. Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (consort 1a). Am J Gastroenterol. 2012;107(12):1888–96.PubMedCrossRef
70.
Zurück zum Zitat George AT et al. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg. 2013;100(3):330–8.PubMedCrossRef George AT et al. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg. 2013;100(3):330–8.PubMedCrossRef
71.
Zurück zum Zitat Thin NN et al. 882 Randomised mixed methods trial of sacral and percutaneous tibial nerve stimulation for faecal incontinence. Gastroenterology. 2014;146(5 Supple 1):S-154.CrossRef Thin NN et al. 882 Randomised mixed methods trial of sacral and percutaneous tibial nerve stimulation for faecal incontinence. Gastroenterology. 2014;146(5 Supple 1):S-154.CrossRef
72.
Zurück zum Zitat Butt S et al. Mo2015 Preliminary significant findings from a randomised control trial of posterior tibial nerve stimulation in systemic sclerosis associated faecal incontinence. Gastroenterology. 2014;146(5):S-717–8.CrossRef Butt S et al. Mo2015 Preliminary significant findings from a randomised control trial of posterior tibial nerve stimulation in systemic sclerosis associated faecal incontinence. Gastroenterology. 2014;146(5):S-717–8.CrossRef
Metadaten
Titel
Management of Pelvic Floor Disorders: Biofeedback and More
verfasst von
David Prichard, MB, PhD
Adil E. Bharucha, MBBS, MD
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology / Ausgabe 4/2014
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-014-0033-8

Weitere Artikel der Ausgabe 4/2014

Current Treatment Options in Gastroenterology 4/2014 Zur Ausgabe

Stomach (C Howden, Section Editor)

Proton Pump Inhibitors and Risk of Bone Fractures

Motility (T Lembo, Section Editor)

Management of Gastroparesis: Beyond Basics

Stomach (C Howden, Section Editor)

Prevention and Treatment of NSAID Gastropathy

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.